01
AI & predictive diagnostics
Where machine learning genuinely improves quality, throughput and interpretation — and where human oversight, validation and governance remain non-negotiable.
Insights
Editorial writing on diagnostics, laboratory transformation and health technology.
Original analysis at the intersection of molecular diagnostics, laboratory automation and the adoption of advanced health technologies — grounded in more than fifteen years of international in vitro diagnostics experience.
Lead story
AI & Predictive Diagnostics · 14 min read · 10 verified references
AI, Predictive Diagnostics and the Future of Laboratory Automation
How artificial intelligence is beginning to reshape clinical laboratories — and why validation, governance and professional oversight remain essential.
Read the articleEditorial pillars
02
Molecular diagnostic services
What it takes to design, validate and scale molecular services in clinical laboratories, from unmet need to sustained utilization.
03
Health technology adoption
Why technically excellent diagnostic technologies fail to reach patients — and what changes when adoption is treated as an operational discipline.
Featured analysis
Molecular Diagnostic Services · 12 min read
Developing and Expanding Molecular Diagnostic Services
What it actually takes to build a molecular diagnostic service in a clinical laboratory — from unmet need to sustained utilization.
All articles
Grounded writing on diagnostics, molecular science and laboratory transformation.
AI & Predictive Diagnostics14 min readStrategic analysis
AI, Predictive Diagnostics and the Future of Laboratory Automation
A grounded look at where AI genuinely adds value across pre-analytical, analytical and post-analytical laboratory workflows, and the guardrails required before deployment.
- AI in diagnostics
- predictive QC
- software as a medical device
- ISO 15189
10 verified references
Molecular Diagnostic Services12 min readPractical guide
Developing and Expanding Molecular Diagnostic Services
A structured view of designing, validating and scaling molecular diagnostic services in regulated environments, drawn from more than a decade of international in vitro diagnostics work.
- molecular diagnostics
- assay validation
- CLSI EP
- laboratory workflow
10 verified references
Health Technology Adoption12 min readMarket brief
Leading the Adoption and Commercialization of Health Technologies
The gap between a scientifically valid diagnostic technology and its actual clinical adoption is rarely a science problem. It is a systems and translation problem.
- health technology adoption
- IVD commercialization
- distributor enablement
- LATAM diagnostics
10 verified references
About the author
Marcela Riaño Caro
Molecular Diagnostics and Laboratory Strategy Leader
Bacteriologist and clinical microbiologist trained at Pontificia Universidad Javeriana with graduate work in molecular biology. More than fifteen years of international diagnostics experience across Abbott Laboratories, DiaSorin and Roche Diagnostics in Canada and Latin America.
- Molecular diagnostics
- In vitro diagnostics
- Laboratory workflow assessment
- Diagnostic portfolio strategy
- Health technology adoption
Editorial standards
Source-anchored
Every non-trivial claim is tied to a public, reputable source.
No medical advice
Content is educational and does not constitute diagnosis or treatment.
Verified experience
Professional experience is described factually and only where documented.
No fabricated evidence
No invented statistics, DOIs, quotes or interviews.
Bilingual parity
English and Spanish versions carry the same substance and citations.